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Background. The role of ß-catenin signaling in mesodermal lineage formation and differentiation has been elusive.
Methodology. To define the role of ß-catenin signaling in these processes, we used a Dermo1(Twist2)Cre/+ line to target a
floxed b-catenin allele, throughout the embryonic mesenchyme. Strikingly, the Dermo1Cre/+; b-cateninf/2 conditional Knock Out
embryos largely phenocopy Pitx12/2/Pitx22/2 double knockout embryos, suggesting that ß-catenin signaling in the
mesenchyme depends mostly on the PITX family of transcription factors. We have dissected this relationship further in the
developing lungs and find that mesenchymal deletion of b-catenin differentially affects two major mesenchymal lineages. The
amplification but not differentiation of Fgf10-expressing parabronchial smooth muscle progenitor cells is drastically reduced.
In the angioblast-endothelial lineage, however, only differentiation into mature endothelial cells is impaired. Conclusion.
Taken together these findings reveal a hierarchy of gene activity involving ß-catenin and PITX, as important regulators of
mesenchymal cell proliferation and differentiation.
Citation: De Langhe SP, Carraro G, Tefft D, Li C, Xu X, et al (2008) Formation and Differentiation of Multiple Mesenchymal Lineages during Lung
Development Is Regulated by b-catenin Signaling. PLoS ONE 3(1): e1516. doi:10.1371/journal.pone.0001516
INTRODUCTION
During development and in adult tissues, mesenchymal cells serve
as precursors to diverse cell lineages, including smooth muscle cells
(SMCs), endothelial cells, pericytes, lipocytes and stromal
fibroblasts. The proper generation of these cell types likely relies
on the controlled amplification of lineage-restricted and non-
restricted mesenchymal precursors followed by their timely
differentiation into the appropriate progeny.
The developing lung provides a good system for studying the
regulators of epithelial and mesenchymal cell lineage formation [1]
and thus regulators of epithelial progenitor fates have been
elucidated. For example, hyperactive b-catenin signaling leads to
aberrant amplification of distal lung progenitor cells, partly through
the regulation of N-myc expression [2,3,4], while targeted disruption
of N-myc results in premature differentiation and reduced epithelial
cell proliferation [2,3]. ß-catenin signaling also regulates the levels of
Bmp4 and Fgfr2b expression in distal lung epithelium [4]. FGFR2b
signaling in turn, is critical for maintenance and expansion of the
pool of epithelial progenitor cells, not only in lungs, but also in
developing pancreas, tooth and skin [5,6,7].
We and others have studied the sequential development of
several lung mesenchymal lineages. The distal lung contains two
distinct mesenchymal cell populations: sub-epithelial; sub-meso-
thelial. Sub-epithelial cells express Ptch and respond to epithelially-
derived SHH, while transient fate analysis studies using an Fgf10-
LacZ reporter line (here after termed Fgf10LacZ/+), show that the
sub-mesothelial cells express high levels of Fgf10 and serve as
progenitors to parabronchial smooth muscle cells (PSMCs). The
PSMC progenitor status is maintained by mesothelialy-derived
FGF9 [8]. With time, the PSMC progenitors relocate around the
bronchi, and under the influence of an epithelially-derived signal,
BMP4, differentiate into PSMCs [9]. The myogenic program is
then completed along the proximal airways, where the progenitors
encounter Laminin-2 and Fibronectin in the epithelial basement
membrane [10,11,12].
Hints that ß-catenin signaling is important for the development
of the mesenchyme, in addition to the epithelium, have emerged
from expression pattern studies and the analysis of TOPGAL and
BATGAL reporter mice. TOPGAL and BATGAL alleles serve as
LEF1/TCF mediated ß-catenin signaling reporters only [13,14]
and their observed activity is restricted to the late/differentiated
mesenchymal derivatives, such as the smooth muscle cells
surrounding the proximal airways and in the mesenchyme around
the trachea [2,4,11]. Furthermore, overexpression of Wnt5a has
been shown to either directly or indirectly regulate Fgf10
expression in the mesenchyme [15] while Wnt7b has been
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demonstrated to act on lung vascular SMCs through Frizzled 1
and LRP5 [16]. Besides LEF1/TCF mediated ß-catenin signaling,
ß-catenin can also act through the PITX family of transcription
factors [17], which are abundantly expressed in developing
mesenchymal tissues [18]. Yet, the precise role and contribution of
ß-catenin-PITX signaling axis in the early development and
specification of mesenchymal lineages has not been studied in detail.
We have carried out a Dermo1Cre/+-mediated conditional
inactivation (CKO) of b-catenin to study the role of ß-catenin
signaling in mouse embryonic mesodermal lineages. In these
mutants, we find multiple mesenchymally-related defects that are
remarkably reminiscent of a double knock out of Pitx1 and Pitx2
genes [19]. By focusing on the lungs of the conditional mutant
embryos and combining fate analysis and global gene expression
pattern studies, we show for the first time that mesenchymal ß-
catenin signaling has a dual, lineage-dependant function. It
regulates the formation and amplification of Fgf10-expressing
PSMC progenitor cells but does not affect their differentiation.
Yet, it is required for proper differentiation of endothelial cells.
These findings reveal a critical requirement for ß-catenin signaling
in the development of multiple mesenchymal lineages.
RESULTS AND DISCUSSION
Phenotypic similarities between Dermo1Cre/+-
mediated inactivation of b-catenin and complete
loss of Pitx1/2
Analysis of 327 embryos from F1 intercrosses revealed that the
Dermo1Cre/+; b-cateninf/- conditional knockout (here on abbreviated to
CKO) is lethal at embryonic day E13.5-E14.5 due to the severe
cardiac (supplemental figure) and vasculogenesis-related defects.
CKO embryos show a set of phenotypes that are remarkably
reminiscent of Pitx2 null embryos. These include: an arrest in turning
of the body axis and defective body wall closure; partial right
pulmonary isomerism; altered cardiac position with major cardiac
outflow tract abnormalities classified as double outlet right ventricle
(DORV) (90%) and Pulmonary truncus arteriosus (PTA) (10%)
(n= 20); defective development of the mandibular and maxillary
facial prominences and regression of the stomodeum (supplemental
Fig. S1) [17,18,20,21,22]. Furthermore, CKO embryos exhibit
minor forelimb and severe hind limb defects (supplemental Fig. S1),
the latter being characteristic of the Pitx1/2 double KO [19].
Several studies have suggested that the ß-catenin signaling
pathway can induce Pitx2 expression, and that direct binding of b-
catenin to PITX2, converts PITX2 into a transcriptional activator
[17]. Our in vivo findings provide the strongest genetic evidence
yet for involvement of a ß-catenin-PITX axis in the formation
and/or differentiation of multiple mesenchymal lineages.
Here on, we study the lung mesenchyme of CKO embryos to
dissect these interactions and decipher their precise role in
mesenchymal cell lineage differentiation.
CKO of b-catenin in lung mesenchyme alters the
growth and patterning of mesenchymal and
epithelial cells
Tomonitor the onset and pattern of Cre activity inDermo1Cre/+ lungs,
we crossed the Dermo1Cre/+ mice [23] with Rosa26R reporter mice
[24] and found a strong Cre-activity detectable in the mesenchyme
surrounding the trachea and primary bronchi illustrated at E11.5
(Fig. 1a) and E13.5. This activity is detectable throughout the
developing mesenchyme but not in the epithelium (Fig. 1b–d).
To validate the specific inactivation of b-catenin in the mesen-
chyme, we compared the pattern and levels of b-catenin expression
in CKO versus wild type lungs by immunofluorescence staining.
Except for occasionally a few patches, we could not detect b-catenin
expression in the mesenchyme of E14.5 CKO lungs and consistent
with the restriction of Cre expression to Dermo1Cre/+ mesenchyme,
epithelial b-catenin expression appeared unperturbed. Persistence of
b-catenin in some small patches of lung mesenchyme is indicative of
a mosaic deletion (Fig. 1l,k) and while this mosaicism may affect the
severity of phenotypes and somewhat complicate our analysis, it also
provides the benefit of an internal control.
Analysis at E12.5 and E14.5 showed that the ß-catenin CKO
lungs have shortened trachea and reduced branching as well as
perturbation of normal stereotypic branching patterns observed in
WT lungs. Moreover, the peripheral mesenchyme was reduced.
The CKO lungs also exhibit partial isomerism such that the left
lobes contained inter-lobular septations – characteristic of the right
side of WT lungs, but lacked an accessory lobe (Fig. 1f,h).
The branching defect in CKO lungs is more severe than just the
right isomerization initially described in Pitx2 hypomorph embryos
and resembles more the phenotype of lungs from mice with a
complete inactivation of Pitx2 [25]. We therefore examined the
impact of CKO on PITX2 expression and asked whether its
homologues, PITX1 and PITX3, are affected by loss of b-catenin.
Immunostaining studies showed that PITX1 is present in both WT
and CKO distal lung epithelium (Fig. 2a,b). Three Pitx2 isoforms
exist a, b and c the latter of which is involved in Left/right asymmetry
and is only expressed on the left side of the lung [22]. PITX2 (using
antibodies recognizing all three isoforms) is normally found in distal
epithelium and mesenchyme but is absent from PSMC around the
bronchi (arrow in Fig. 2c), and as expected, PITX2 levels were found
to be drastically reduced in the CKO mesenchyme (Fig. 2d). By
contrast, PITX3 is expressed exclusively in the differentiated smooth
muscle cells around the bronchi in both WT and CKO lungs
(Fig. 2e–h), suggestive of a switch from PITX2 to PITX3 expression
upon PSMC differentiation. Although the significance of this switch
needs to be elucidated, our findings indicate a major impact on
PITX2 expression at the protein level.
Loss of b-catenin signaling affects the sub-
mesothelial but not sub-epithelial mesenchyme and
diminishes FGF signaling
We analyzed the expression of a set of lineage and cell type-specific
marker genes to examine whether all or just a subset of
mesenchymal cells are affected by the loss of b-catenin signaling.
In the developing lungs, Fgf10 is expressed by the PSMC
progenitors, which are sub-mesothelial in origin [26]. Localized
expression of Fgf10 in the distal mesenchyme also drives the
stereotypic branching observed during early lung development
[27]. Except for a few patches in the right lobes, levels of Fgf10
were greatly reduced in E13.5 CKO lungs (Fig. 3a,b) and these
patches likely reflect the mosaicism of ß-catenin inactivation.
Vibratome sections showed that in the left lobes there is almost
complete absence of Fgf10 expression (insets in Fig. 3a,b).
Interestingly, we also found a marked reduction in Spry2
expression in the distal epithelium of CKO lungs (Fig. 3c,d). As
a read out, Spry2 reduction is indicative of reduced epithelial FGF
signaling and correlates with decreased epithelial branching [26].
We then examined whether the sub-epithelial distal mesenchy-
mal domain, was similarly affected. Expression of Shh (Fig. 3e,f)
and Ptch (Fig. 3g,h) was assessed but no differences between WT
and CKO sub-epithelial mesenchyme were observed. However,
the sub-mesothelial mesenchymal domain in CKO lungs contain-
ing the Fgf10-expressing progenitors was lost (Fig. 3g,h inset).
Taken together, this suggests that b-catenin signaling specifically
Lung b-Catenin Signaling
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regulates the Fgf10-expressing progenitor cells in the sub-
mesothelial mesenchyme.
We have previously shown that mesenchymal FGF signaling is
important for the expression of Fgf10 within, and for the ensuing
survival and proliferation of distal PSMC mesenchymal progen-
itors [28]. Mesenchymal FGF signaling induced by FGF9 is also
important for preventing the differentiation of PSMC progenitors
[8,28]. Spry4, expressed in the distal mesenchyme is a faithful
reflector of levels of FGF signaling in this tissue compartment [28].
Interestingly, we found that levels of Spry4 were also reduced in
CKO lungs suggestive of reduced levels of mesenchymal FGF
signaling (Fig. 3i,j).
We then compared the expression of Bmp4 in the epithelium of
WT and CKO lungs as BMP4 engages the Fgf10 expressing
progenitors into the smooth muscle cell lineage [9,29]. However,
no difference in Bmp4 expression between WT and CKO lungs
was observed (data not shown) suggesting that the differentiation of
the PSMC progenitors could occur normally in CKO lungs.
Mesenchymal defects in CKO lungs do involve a
gradual loss of PITX
Next, we used an imported TOPGAL reporter allele to examine the
level and distribution of LEF1/TCF-mediated b-catenin signaling.
At E13.5, TOPGAL activity was restricted to epithelium, in both
WT and CKO lungs, with no discernable difference in levels
(Fig. 3k,l). This finding further confirms that in the CKO mice, b-
catenin is specifically deleted in the mesenchyme but importantly, it
also demonstrates that mesenchymal b-catenin signaling at E13.5
does not rely primarily on LEF1/TCF transcription factors.
As the ß-catenin-PITX2 pathway has previously been shown to
regulate Pitx2 expression itself, both at the level of transcription [17]
and mRNA stability [30], we compared the levels of Pitx2 expression
in CKO and WT lungs by in situ hybridization. Using a riboprobe
that detects all three isoforms of Pitx2, we found that at E13.5, CKO
lungs show an absence of Pitx2 expression (Fig. 3m,n) further
validating the IHC-derived observations (Fig. 2a,b). Previous studies
reported that in the embryonic lung both PITX2 and LEF1 are
present in the mesenchyme suggesting potential redundant function
between these 2 transcription factors [31,32,33]. However, contrari-
ly to Pitx2 inactivation which leads to abnormal lung development,
Lef1 inactivation does not affect lung development [34], indicating
that PITX2 can compensate for the loss of LEF1 but not vice versa.
This observation argues for a privileged ßcatenin-PITX2 signaling
axis in the embryonic lung mesenchyme.
Remarkably, at E11.5, CKO embryos already exhibit a Pitx1/2
KO-like phenotype even though Pitx2 expression is not fully
extinguished at this stage (Fig. 3o,p). This observation indicates
Figure 1. Decreased branching, partial right isomerization and epithelial proximalization in CKO lungs. (a–d) b-gal staining of Dermo1Cre/+/
Rosa26RWT lungs at E11.5 and E13.5 reports Cre recombination activity in the mesenchyme of the embryonic lung. (a–b)Whole mount pictures of b-
gal staining. (c) Vibratome section through E13.5 lung. (d) Paraffin section through E13.5 b-gal stained lung and counterstained with eosin. (e–h) (e)
E12.5 WT and (f) CKO lungs which show decreased branching. (g) E14.5 WT lung and (h) CKO lung which shows partial right isomerization,
astereotypic branching and a grape like structure, and absence of trachea. (i–j) H&E staining of sections through the left lobe of (i) E14.5 WT and (j)
CKO lungs. Left lobe of CKO lung features proximalized airways and partial lobular septation. (k–l) Immunostaining for b-catenin on sections of (k)
E14.5 WT and (l) CKO lungs show a mosaic deletion of b-catenin throughout the lung mesenchyme.
doi:10.1371/journal.pone.0001516.g001
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that loss of mesenchymal b-catenin per se does not immediately
result in loss of Pitx2 expression, but a b-catenin/PITX2
interaction is required for mesenchymal ß-catenin signaling.
Fgfr2 is a downstream target of b-catenin signaling
in the mesenchyme
The observed reduction in Fgf10 and Spry4 expression, indicative of
reduced FGFR2C signaling in CKO lung mesenchyme, led us to
investigate its mechanism. Shu et al., (2005) reported that
inactivation of b-catenin in the distal lung epithelium, leads to a
down-regulation of Fgfr2 receptor in the epithelium. By inactivating
b-catenin in the lung mesenchyme, we might expect to observe a
similar down-regulation of Fgfr2 in the mesenchyme. Using
immunohistochemistry, we found that indeed FGFR2 expression is
reduced in the mesenchyme but not epithelium of CKO lungs
(Fig. 4a,b). Interestingly, FGFR2 expression is also reduced in
Pitx22/2 lungs (supplemental Fig. S2). In this case, however, FGFR2
expression was also reduced in the epithelium, as Pitx2 deletion was
not mesenchyme specific. To further address how ß-catenin signaling
in the mesenchyme regulates Fgfr2 expression, we silenced b-catenin
and Pitx2 expression using siRNA in primary cultures of WT
mesenchyme and monitored using real time PCR the levels of Fgfr2
expression. Using siRNA in primary cultures of lung mesenchyme, a
downregulation in b-catenin expression of 33%68 (n=3, P= 0.03)
compared to scrambled led to a corresponding downregulation in
Fgfr2 expression of 40%64 (n=3, P= 0.003) (Fig 4l). Similarly, a
downregulation in Pitx2 expression of 50%68 (n=3, P= 0.01)
compared to scrambled led to a corresponding downregulation in
Fgfr2 expression of 40%66 (n=3, P= 0.009) (Fig. 4l).
Next, we set out to investigate if this relationship is reflected in
functional assays. We quantified the distribution of P-ERK
positive cells and found much fewer P-ERK positive cells in the
mesenchyme of CKO lungs wherever b-catenin was deleted
(0.160.1% vs. 160.2%, n= 3, P=0.03) (Fig. 4d,c arrows). The
number of P-ERK positive cells in the epithelium was also reduced
in CKO lungs and this correlates with the reduction in Spry2
expression (160.3% vs. 360.35%, n= 3, P= 0.03). There was also
a clear reduction in the number of mitotic cells, as determined by
Phospho-Histone H3 (PH3) staining, in mesenchyme (0.260.1%
vs. 1.160.1%, n= 3, P=0.02) (Fig. 4f,e) and epithelium (260.2%
CKO vs. 3.260.2% WT, n= 3, P=0.03) of CKO, when
compared to WT.
Interestingly, no significant differences in P-ERK or PH3 could
be found in areas of CKO lung mesenchyme that lacked
recombination (P-ERK 1.360.1% vs. 1.160.2% P=0.2) (PH3
1.560.2% vs. 1.160.1%, n= 3, P=0.2), demonstrating that the
effect of b-catenin deletion in CKO lungs on mesenchymal
proliferation and ERK phosphorylation is cell autonomous.
We also tested the response of CKO and WT lung explants to
FGF9 treatment, which in a normal scenario would stimulate the
proliferation of sub-mesothelial mesenchyme and cause dilation of
the epithelium, effects that are brought about by FGFR2 signaling
[8,35] (Fig. 4i,g). Treatment of CKO lungs lead to dilation of the
distal epithelium (Fig. 4j,h) but the corresponding mesenchyme
was markedly thinner, when compared to the FGF9-treated WT
lungs (Fig. 4j,i), indicative of a reduced mesenchymal response to
FGF9 involving reduced FGFR2 expression. In support of this, we
found much lower level of ERK phosphorylation in CKO explants
treated with FGF9, and reduced expression of FGFR2 itself in
non-treated cultures, when compared to WT (Fig. 4k).
In this system, we also found that PITX2 expression is
decreased in CKO lung mesenchyme. Finally, a set of immuno-
precipitation studies indicated that PITX2 is not only a
downstream target of b-catenin signaling in the lung but also
binds to b-catenin (Fig. 4k). However, under similar experimental
conditions, we could not find an interaction between b-catenin
and PITX3 proteins (Fig. 4k).
Taken together these results support the notion that Fgfr2 is a
specific downstream target gene in the b-catenin/PITX2 pathway
Figure 2. Expression pattern of PITX members in the developing wild type and mutant embryonic E13.5 lungs. (a–h) Immunostaining for PITX
family members and a-SMA. (a,b) PITX1 expression in wild type lung is detected throughout the distal epithelium. (b) Expression of PITX1 in the CKO
lung is not changed compared to WT. (c) PITX2 expression in wild type lung is detected throughout the epithelium as well as in the mesenchyme at
the exception of the mesenchyme directly surrounding the proximal epithelium (arrows). (d) In CKO lungs, PITX2 expression is drastically reduced in
the epithelium and mesenchyme. (e) In wild type lungs, PITX3 expression is present in the differentiated PSMCs adjacent to the bronchi. (f) In CKO
lungs, PITX3 expression is no longer found as a continuous layer around the bronchi likely reflecting a defect in the formation of the PSMC. (g, h) SMA
expression on the same section as (e) and (f).
doi:10.1371/journal.pone.0001516.g002
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of the mesenchyme. Conditional deletion of b-catenin in the lung
mesenchyme results in the functional inactivation of the FGFR2c
signaling pathway. In turn, this affects the sub-mesothelial
mesenchymal domain containing the PSMC progenitor cells,
which is known to depend on mesenchymal FGF signaling for its
maintenance and proliferation [8,28].
Reduction of PSCM cells correlates with loss of
c-Myc expression
The loss of proliferation noted in CKO lungs led us to measure the
levels of c-Myc expression, which is known to be a ß-catenin/
PITX2 signaling target gene [17] and key regulator of cell
Figure 3. Reduced Fgf10, Spry2, Spry4 and Pitx2 expression in CKO lungs. Gene expression in E13.5 lungs by WMISH and LacZ staining in WT and
CKO lungs (n = 3 for each probe). (a–b) Fgf10 expression is reduced in the sub-mesothelial mesenchyme of CKO lungs. Inset: vibratome section
through the distal left lobes. (c–d) Spry2 expression is reduced in the epithelium of CKO lungs. (e–f) No difference in Shh or (g–h) Ptch expression
levels in CKO lungs compared to WT lungs. Inset : vibratome section through the distal right lobes. (i–j) Spry4 expression is reduced in the distal
mesenchyme of CKO lungs illustrating reduced mesenchymal FGF9 signaling. (k–l) b-gal staining of TOPGAL lungs shows similar levels of TOPGAL
activity in WT and CKO lungs illustrating the specificity of the b-catenin deletion throughout the mesenchyme. (o–n) Pitx2 is completely ablated in
CKO lungs at E13.5. (o–p) Pitx2 expression is still present in E11.5 CKO embryos even though the Pitx22/2 phenotype is already apparent indicating
that interaction of PITX2 with b-catenin is necessary for b-catenin signaling.
doi:10.1371/journal.pone.0001516.g003
Lung b-Catenin Signaling
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proliferation [36]. As shown in Fig. 5a, c-Myc is normally expressed
in the mesenchyme but its expression levels are drastically reduced
both in CKO lungs (Fig. 5a,b) and in Pitx22/2 lungs (supplemental
Fig. S2). c-Myc expression was maintained in the regions where b-
catenin was not deleted (Fig. 1l), serving therefore as an internal
control and indicating further that these effects are cell
autonomous. Together with the proliferation data presented
earlier (Fig. 4c,d), these results support the conclusion that ß-
Figure 4. Reduced FGFR expression, P-ERK and proliferation in CKO mesenchyme. (a–b) Immunohistochemistry. Reduced expression for FGFR2 in
E13.5 CKO lung mesenchyme. Expression in the CKO epithelium is unaffected. (c–d) Immunofluorescence for phospho-ERK (P-ERK) in green (arrows)
and b-catenin in red, DAPI (Blue). (e–f) Immunofluorescence for phospho-HistonH3 (PH3) in green and b-catenin in red, DAPI (Blue) (g–j) H&E stained
sections through E12.5 WT and CKO lungs cultured for 48h in vitro in the presence or absence of 200 ng/ml FGF9. (g,i) WT lungs grown in the
presence of FGF9 (i) show decreased branching, dilation of the epithelium and overproliferation of the distal mesenchyme compared to untreated
lungs (g). (h,j) CKO lungs grown in the presence of FGF9 (j) only show an epithelial effect and dilation of the epithelium while proliferation of the
distal mesenchyme remains absent. (k) Upper part: western blot analysis on primary culture of WT and CKO lung mesenchyme treated or not with
FGF9 with P-ERK, total-ERK, PITX2 and FGFR2 antibodies. Lower part: Co-Immunoprecipitation of PITX2 with b-catenin from primary culture of wild
type lung mesenchyme cultured in the presence of 10 mM LiCl. Absence of co-immunoprecipitation of PITX3 with b-catenin from primary culture of
wild type lung mesenchyme. (l) Relative b-catenin, Fgfr2 and Pitx2 expression levels in primary cultures of mesenchyme treated with siRNA to b-
catenin (top) and Pitx2 (bottom) analyzed by real time PCR.
doi:10.1371/journal.pone.0001516.g004
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catenin signaling drives the proliferation of Fgf10-expressing sub-
mesothelial cells.
Next, we examined the consequence of this reduced cell
proliferation on parabronchial smooth muscle formation around
the bronchi, since sub-mesothelial mesenchymal progenitors con-
tribute to these muscles. Immunofluorescent staining with SMA-
specific antibodies revealed that the continuity of the PSMC layer
around the bronchi of the CKO lungs is compromised (Fig. 5d,c).
The presence of some PSMC cells indicates that loss of b-catenin per
se does not necessarily affect the differentiation of the progenitors
into smooth muscle cells, but reflects a reduction in the pool of
PSMC progenitors. Moreover, the presence of PSMCs indicates that
some expansion of the PSMC progenitor pool did occur.
We also tested the potential of CKO mesenchymal cells to
differentiate into smooth muscle cells in vitro and found this
unperturbed [37] because, like WT cells, cultured CKO cells
readily differentiated into SMC (Fig. 5e,f). Raising the level of FGF
signaling in the mesenchyme by FGF9-treatment normally inhibits
the SMC differentiation [11], but FGF9 stimulation had no such
effect on CKO-derived cells (Fig. 5g,h). We also carried out a
similar IF experiment to detect P-ERK expression. Treatment of
WT cells with FGF9 results in a 116 %68.7 (n = 3, P= 0.005)
increase in P-ERK (Fig. 5k,i). By contrast, treatment of CKO cells
with FGF9 leads only to a modest 70%63.5 (n = 3, P= 0.001)
increase in P-ERK levels (Fig. 5l,j). These observations demon-
strate further that CKO cells have the capacity to differentiate into
smooth muscle cells, but are unable to sufficiently respond to
FGF9’s inhibitory effect, most likely because FGFR2 is function-
ally downregulated following conditional deletion of b-catenin
(Fig. 4a,b,k).
Mesenchymal b-catenin signaling is essential for the
amplification of the Fgf10 expressing PSMC
progenitors and differentiation of the angioblasts
into mature endothelial cells
So far, we have provided experimental evidence suggesting that
CKO deletion of b-catenin in the lung mesenchyme perturbs the
amplification but not the differentiation of the PSMC progenitors
into smooth muscle cells. To directly visualize the fate of the Fgf10-
expressing progenitors, we crossed our mutant mice with a
previously published Fgf10LacZ enhancer-trap line [38]. Due to the
stability of the LacZ protein, this line can be used to lineage trace
transiently the Fgf10 expressing PSMC progenitors [9]. CKO
lungs showed a marked reduction in Fgf10/LacZ expressing
progenitors in the distal mesenchyme at E13.5 vs. WT lungs
(Fig. 6b,a). Close analysis of the accessory lobe further illustrated
the presence of single progenitor cells in the distal mesenchyme of
the CKO lung (Fig 6b’,a’ arrowhead) and patchy LacZ expression
around the bronchi compared to WT lungs (Fig. 6b’,c’ arrows).
Immunhistochemistry for b-catenin on paraffin sections of CKO
lungs crossed with the Fgf10LacZ reporter reveals that expression of
Fgf10 in the distal mesenchyme of CKO lungs is not due to the
Figure 5. Reduced c-Myc expression and lack of PSMC progenitor amplification in CKO lungs. (a-b) Section RISH for c-Myc on E14.5 WT and CKO
lungs. Expression of c-Myc is lost in CKO lung mesenchyme were b-catenin is completely deleted but remains the same were b-catenin expression is
unaltered. These sections are adjacent to the ones represented in Fig. 1k,l illustrating mosaic b-catenin deletion. (c-d) Immunofluorescence for b-
catenin (green) and a-SMA (red) on sections through E13.5 WT and CKO lungs. Absence of b-catenin in CKO lung mesenchyme and patchy a-SMA
expression around the bronchi (d) and high magnification inset in (d). (e–f) Untreated primary cultures of mesenchyme from both WT and CKO lungs
spontaneously differentiate into smooth muscle cells in vitro. (g–h) Primary cultures from WT lungs treated with FGF9 fail to differentiate into smooth
muscle cells (g) while primary cultures from CKO lungs (h) are not affected in their differentiation after FGF9 treatment. (i–l) Immunofluorescence for
b-catenin (green) and P-ERK (red) on primary culture of WT and CKO lung mesenchyme treated or not with FGF9. Upon FGF9 treatment, Note the
drastic increase in P-ERK expression in WT cells in comparison to CKO cells.
doi:10.1371/journal.pone.0001516.g005
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lack of recombination of the ß-cateninflox allele (Fig. 6c,d). This
confirms our previous observation that ß-catenin signaling in the
lung mesenchyme is important for the amplification of the PSMC
progenitors or transient amplifying cells. We then examined
whether the loss of ß-catenin signaling affects the differentiation of
the lung mesenchyme into endothelial cells. For this, CKO lungs
were generated in a Flk1LacZ reporter background [39], which
expresses LacZ under the control of the endogenous Flk1 promoter.
Flk1 is an early marker of angioblast and its expression is
maintained in mature endothelial cells [39]. Interestingly, Flk1
expression was highly upregulated throughout the entire CKO
embryo (Fig. 6k,l) including the lungs (Fig. 6e,f). Ablation of
mesenchymal ß-catenin signaling therefore did not seem to
interfere with the specification and amplification of the angioblast.
However, PECAM and endothelial-Claudin5 staining on CKO
lungs vs. WT lungs revealed an impaired differentiation of the
angioblasts into mature endothelial cells and blood vessels in the
CKO lungs vs. WT lungs (Fig. 6g–j). We also examined the
pattern of vasculature by injecting India ink in the left ventricle of
the CKO and WT hearts, only to find a clear defect in
vasculogenesis throughout the CKO embryo (Fig. 6m,n). Leakage
of India ink from abnormal and immature blood vessels could be
observed throughout the CKO embryo. A similar underdeveloped
vascular system was also observed in Pitx22/2 embryos after
Intracardiac India ink injection (supplemental Fig. S2). However,
PECAM staining could still be detected in endothelial cells of
Pitx22/2 embryos (data not shown) indicating a possible
redundancy with other PITX or LEF1/TCF transcription factors.
Our results indicate that inactivation of b-catenin in the
mesenchyme inhibits the differentiation of angioblasts into mature
endothelial cells. However, it is important to note that ablation of
b-catenin in mature endothelial cells using the Tie2Cre driver line did
not affect vasculogenesis and angiogenesis, or PECAM expression
[40]. Tie2 expression starts later during endothelial cell differen-
tiation and so our data suggests that ß-catenin signaling is an
important regulator of early endothelial cell development [41,42].
Mesenchymal b-catenin signaling controls the
amplification of PSMC progenitors in the sub-
mesothelial mesenchyme
Figure 7 summarizes and places our findings in the context of
mesenchymal cell differentiation in the lung. Previously, we have
shown that Fgf10-positive cells (represented in blue in model
Fig. 7c) present in the sub-mesothelial mesenchyme can serve as
PSMC progenitors [9], and that their proliferation is driven by
FGF9 produced by the mesothelium [8,28]. Here, we demonstrate
that the amplification of these transient amplifying cells relies on
b-catenin signaling via PITX2. Moreover, this important role of
b-catenin signaling involves the regulation of FGFR2c and c-Myc
expression in that loss of b-catenin diminishes the response of sub-
mesothelial mesenchyme to mesothelially-derived FGF9, resulting
in a dramatic reduction in the pool of Fgf10-expressing PSMC
progenitors, contained within the sub-mesothelial mesenchyme.
This impairment has also been observed in the lungs of Fgf92/2
embryos [35,43]. Interestingly, b-catenin abrogation in the
mesenchyme specifically interferes with the amplification of the
PSMC progenitors but does not affect, at least in vitro, their
differentiation into smooth muscle cells.
As PSMC progenitors relocate around the bronchi, they are
exposed to high levels of epithelial BMP4, and eventually stretch
out on the epithelial basement membrane which engages them
into the smooth muscle cell lineage [9,11], and there appears to be
a switch from PITX2 to PITX3 expression.
Our data suggest that PITX2 and 3 have distinct effects on cell
fate and seem to be differently affected by the deletion of b-catenin.
We propose that mesenchymal b-catenin signaling in the sub-
mesothelial mesenchyme acting at least in part via PITX2 is
necessary for the amplification of the PSMC progenitors or at least
the proliferation of the transient amplifying cells derived from the
Fgf10 expressing PSMC progenitors. Use of the Fgf10LacZ reporter
shows that single Fgf10/LacZ positive PSMC progenitors are
present in the distal mesenchyme of CKO lungs. The presence of
these cells may indicate that b-catenin signaling is required for
asymmetrical division of these progenitors into PSMC precursor
cells. Deletion of b-catenin in the progenitor cells leads to impaired
formation of transient amplifying cells, revealing the single Fgf10/
LacZ expressing PSMC progenitors in the CKO lungs. However,
deletion of b-catenin in the progenitors or the transient amplifying
cells does not inhibit their differentiation into smooth muscle cells,
which coincides with a switch in expression from PITX2 to
PITX3. On the contrary, FGF9 is no longer capable of
maintaining the undifferentiated state of mesenchymal cells,
effectively allowing them to differentiate prematurely.
Paradoxically, ß-catenin signaling seems to play the opposite
role in the other major mesodermally derived cell lineage, the
endothelial cell lineage. In the whole CKO embryo and in the
lung in particular, we observe an amplification of Flk1-positive
angioblasts. We propose that absence of b-catenin prevents them
from differentiating into mature endothelial cells. Interestingly c-
Myc, which is down-regulated in the CKO lung mesenchyme, has
also previously been shown to be essential for vasculogenesis and
angiogenesis during development and tumor progression [44].
In conclusion, our data indicate that ß-catenin signaling in the
undifferentiated lung mesenchyme is mediated by members of the
PITX family of transcription factors and exhibits a duality in
effect, being necessary for the amplification of the Fgf10-expressing
PSMC progenitors on the one hand and the proper differentiation
of angioblasts into mature endothelial cells on the other.
MATERIALS AND METHODS
Transgenic embryos
b-cateninf/f; CMV-Cre, Rosa26R, Flk1LacZ/+ and TOPGAL, mice
were obtained from The Jackson Laboratory. Dermo1Cre/+ mice
were a kind gift from Dr. David Ornitz [23], Fgf10LacZ/+ mice were
a generous gift from Dr. Robert Kelly [38] and Pitx22/2 embryos
were a kind gift of Dr. James Martin [21]. b-catenin heterozygotes
were obtained by crossing floxed b-catenin mice with CMV-Cre
mice. b-catenin+/2 mice were crossed with Dermo1Cre/+ mice to
obtain double heterozygous males, which were then crossed with
b-cateninf/f females. Also b-cateninf/f/Rosa26R+/+; b-cateninf/f/TOP-
GAL+/+; b-cateninf/f/Flk1Lacz/+ and b-catenin/Fgf10LacZ/+ mice were
created by intercrossing b-cateninf/f mice with the respective mouse
reporter lines.
b-galactosidase staining
Tissues containing Rosa26R, Flk1LacZ, TOPGAL or Fgf10LacZ alleles
were dissected and b-galactosidase staining was performed as
previously described [11].
In situ hybridization
WMISH was performed like previously described [28]. Paraffin
sections of embryonic lungs were hybridized using a protocol
adapted from [45]. The following mouse cDNAs were used as
templates for the synthesis of digoxigenin-labeled riboprobes: a
1.5 kb full-length mouse Bmp-4, a 642 bp Shh, a 584 bp fragment
of Fgf10, a 1.1 kb Spry4 probe, a 948 bp full-length mouse Spry2
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Figure 6. Lack of PSMC progenitor amplification and failure of endothelial progenitor cell differentiation. (a–b’) b-gal staining on WT and CKO lungs
crossed with the Fgf10LacZ reporter line. b-gal staining in the CKO lung (b) is severely reduced and the presence of single progenitor cells are apparent. (a’–
b’) Close up on the accessory lobe shows the presence of single Fgf10LacZ positive PSMC progenitor cells in the distal mesenchyme of the CKO lung.
Lineage tracing of the Fgf10LacZ positive PSMC progenitor cells in CKO lungs (b’) shows fewer cells are relocating around the bronchi compared to the WT
lungs (a’). (c–d) IHC for b-catenin (brown staining) on paraffin sections of WT and CKO lungs crossed with the Fgf10LacZ reporter. (d) Presence of b-gal
Lung b-Catenin Signaling
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cDNA, a 841 bp fragment of Ptch, a 559 bp fragment from Pitx2
present in all 3 Pitx2 isoforms (cloned by RT-PCR using primers
Pitx2-F gcagaggactcatttcacta and Pitx2-R tataaacgtacggaggagtc)
and a 201 fragment of c-Myc (cloned by RT-PCR using primers c-
Myc-F accaacaggaactatgacctc and c-Myc-R aaggacgtagcgaccgcaac).
Isolation of mesenchymal cells
Mesenchymal cells from E13.5 WT and CKO lungs were isolated
according to [46].
Immunochemistry
E13.5 CKO and WT lung mesenchymal cells were grown on 8
well permanox Lab-Tek chamber slides in the presence of FGF9
(200 ng/ml) for 24 hours. The cells were fixed for 30 minutes with
4% paraformaldehyde and subsequently washed with PBS. Lungs
were fixed in 4% PFA washed in PBS, dehydrated and paraffin
embedded. Lung sections and slides were treated with a
monoclonal anti a-smooth muscle actin antibody (Ab), clone
1A4, Cy3 conjugated (from SigmaH) at 1:200, anti-b-catenin Ab
(BD biosciences) 1:200, anti-PH3 Ab (cell signaling) 1:100, anti-
PERK Ab (cell signaling) 1:100, anti PECAM Ab (BD biosciences)
1:50, anti FGFR2 (Bek) Ab (Santa Cruz) 1:50, anti-Nkx2.1 Ab
(TTF1) (Neomarkers), PITX1 and PITX3 were generated in Dr.
Drouin’s laboratory and were described previously [47,48]. Ab
against PITX2 were a kind gift of Dr. Hjalt [33]. Alternatively,
PITX3 Ab from (Zymed) were also used. Dako cytomation CSAII
signal amplification system was used for FGFR2 immunohisto-
chemistry and slides were mounted using DPX. For immunoflu-
orescence, FITC and CY3 conjugated F(ab’)2 fragments were
purchased from Jackson Immunoresearch and slides were
mounted with DAPI containing VectashieldH.
Western blot and immunoprecipitation
Western blot and Immunoprecipitation studies using antibodies
against P-ERK, total ERK, FGFR2 and PITX2 were carried out
as previously described [9]. Cell lysates from primary culture of
WT or CKO lung mesenchymal cells were immunoprecipitated
with b-catenin antibodies and analyzed by western blot for the
presence of a PITX2/b-catenin or PITX3/b-catenin complexes.
Primary cultures were grown in the presence of 10 mM LiCl to
study the interaction of ß-catenin and PITX2 or were serum
starved to study the interaction of ß-catenin with PITX3.
siRNA transfection
Pre-validated siRNA pools targeting mouse b-catenin and Pitx2
Dharmacon (ON-TARGETplus SMARTpool) were used. b-
catenin and Pitx2 siRNA or scrambled siRNA were transfected
into primary cultures of lung mesenchymal cells using Lipofecta-
mine LTX (Invitrogen) according to the manufacturer’s instruc-
tions. Mesenchymal cells at a density of 16104 cells per well in 12-
well plates were transfected in triplicate with 50 mM siRNA. The
percentage of silencing of b-catenin and Pitx2 and the effect on
Fgfr2c expression were detected by real-time PCR as previous
described [28].
r
staining in the distal mesenchyme in the absence of b-catenin expression (arrow). (e–f) b-gal staining on WT and CKO lungs crossed with the Flk1LacZ
reporter line. High magnification of E13.5 left lobes show an increase in Flk1LacZ expression in the CKO lung compared to WT lungs. Arrowheads illustrate
the reduction in size of the sub-mesothelial mesenchymal domain containing the Fgf10 expressing PSCM progenitors and in which no Flk1-positive cells
are present. (g–h) Immunofluorescence staining for PECAM on E14.5 WT and CKO lungs. Absence of PECAM in CKO lungs (f). (i–j) Immunofluorescence
staining for endothelial-Claudin5 on E14.5 WT and CKO lungs. Absence of endothelial-Claudin5 in CKO lungs (f). (k–l) b-gal staining on E13.5 WT and CKO
embryos crossed with the Flk1LacZ reporter line. CKO embryos (l) show and increased expansion of Flk1LacZ positive angioblasts throughout the embryonic
mesenchyme compared to WT embryos (k). (m–n) Intracardiac India ink injection of E13.5 WT and CKO embryos. CKO embryos show defects in
vasculogenesis and leakage of India ink from premature blood vessels is apparent (n) compared to WT embryos (m).
doi:10.1371/journal.pone.0001516.g006
Figure 7. Model for lineage differentiation of the PSMCs. Fgf10 and Pitx2 expressing PSMC progenitors are located in the submesothelial
mesenchyme and respond to FGF9 and b-catenin signaling to amplify and remain undifferentiated [8,9,28,35]. As the epithelium grows out, the PSMC
progenitors come in contact with BMP4 secreted by the epithelium. These cells then stop expressing Fgf10 and get committed to the PSCM lineage
[9]. When these cells eventually spread out on the epithelial basement membrane containing Fibronectin [11], they differentiate into mature PSMC
and start to express a-SMA and switch from PITX2 to PITX3 expression.
doi:10.1371/journal.pone.0001516.g007
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Proliferation and PERK study
Proliferation and PERK assays were performed as previously
described in [28]. Quantification of PERK levels in Fig. 5 in
primary cultures of mesenchyme was performed using ImageJ
software (NIH).
Organ culture
Lung explants isolated from E12.5 WT and CKO embryos were
cultured and treated with 200 ng/ml FGF9 (R&D systems) as
previously described [8].
Intracardiac ink injections
India ink was injected intracardially with custom made glass
pipettes (12 mm opening) at E13.5. After injections, embryos were
fixed in 4% formaldehyde for 12 hours, dehydrated and cleared in
benzyl benzoate:benzyl alcohol (2:1).
SUPPORTING INFORMATION
Figure S1 Inactivation of b-catenin in the mesenchyme resembles
the phenotype of Pitx2 null embryos. (a) Frontal images of control
and CKO embryos at E13.5. (b-c) Ectopic hearts and visceral
organs in CKO’s vs. WT with leftward displacement of ventricles
(pseudo-colored in green). (d,e) b-galactosidase staining of WT or
CKO embryos containing the Fgf10LacZ allele. CKO embryos
display severe hind limb defects with no detectable LacZ/Fgf10
expression (inset in e). (f,g) Defective development of the
mandibular and maxillary facial prominences and regression of
the stomodeum. (h, i) Altered cardiac position with major cardiac
outflow tract abnormalities in CKO heart (i) compared to WT (h).
In WT, the pulmonary trunk (PT) rises from the right ventricle (rv)
and is separated from the aorta (Ao), which rises from the left
ventricle, by the aortic-pulmonary septum (rv and PT pseudo-
colored in blue, lv and Ao in yellow). (j-r) Histology of control (j-l)
and mutant (m-r) at E13.5 (transverse sections on comparable
axial levels from rostral to caudal). Most mutants display double
outlet right ventricle or DORV (m, n), i.e., both the aorta and
pulmonary trunk originate from the right ventricle. A subset of
mutants demonstrates a single outflow tract rising from the right
ventricle, i.e., they display Pulmonary truncus arteriosus or PTA
(p-r). Leftward orientation of the heart is evident in all mutants;
moreover the right ventricle is largely located above the left
ventricle (m-r).
Found at: doi:10.1371/journal.pone.0001516.s001 (4.86 MB TIF)
Figure S2 Comparative analysis of the Pitx22/2 phenotype. (a-
b) Images of control and Pitx22/2 embryos at E12.5. (c-d)
Immunohistochemistry. Reduced expression for FGFR2 in E12.5
Pitx22/2 lung mesenchyme and epithelium (d) compared to WT
lungs (c). (e-f) Section RISH for c-Myc on E12.5 WT and Pitx22/2
lungs. Expression of c-Myc is reduced in Pitx22/2 lung mesen-
chyme (f) compared to WT lung mesenchyme (e). (g-h)
Intracardiac India ink injection of E12.5 WT and Pitx22/2
embryos. Pitx22/2 embryos show defects in vasculogenesis and
leakage of India ink from premature blood vessels is apparent (g)
compared to WT embryos (h).
Found at: doi:10.1371/journal.pone.0001516.s002 (10.05 MB
TIF)
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